Publicaciones

Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.

The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants.

Predictability of B cell clonal persistence and immunosurveillance in breast cancer.

Targeting Viral Transcription for HIV Cure Strategies.

Science Shops as key intermediary structures to respond to the current health research agenda bias: Evidence from the InSPIRES project.

'Vagus Nerve Dysfunction in the Post-COVID-19 Condition' - Author's reply.

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.

Reduced Cortical Thickness Correlates of Cognitive Dysfunction in Post-COVID-19 Condition: Insights from a Long-Term Follow-up.